Annual Working Capital
$116.39 M
-$9.19 M-7.32%
December 31, 2023
Summary
- As of February 8, 2025, ACRV annual working capital is $116.39 million, with the most recent change of -$9.19 million (-7.32%) on December 31, 2023.
- During the last 3 years, ACRV annual working capital has risen by +$115.28 million (+10423.42%).
- ACRV annual working capital is now -7.32% below its all-time high of $125.58 million, reached on December 31, 2022.
Performance
ACRV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$174.16 M
+$3.09 M+1.81%
September 30, 2024
Summary
- As of February 8, 2025, ACRV quarterly working capital is $174.16 million, with the most recent change of +$3.09 million (+1.81%) on September 30, 2024.
- Over the past year, ACRV quarterly working capital has increased by +$38.97 million (+28.83%).
- ACRV quarterly working capital is now at all-time high.
Performance
ACRV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ACRV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | +28.8% |
| 3 y3 years | +10000.0% | +28.8% |
| 5 y5 years | +10000.0% | +28.8% |
ACRV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +19.4% | at high | +141.0% |
| 5 y | 5-year | -7.3% | >+9999.0% | at high | +141.0% |
| alltime | all time | -7.3% | >+9999.0% | at high | +141.0% |
Acrivon Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $174.16 M(+1.8%) |
| Jun 2024 | - | $171.07 M(+65.9%) |
| Mar 2024 | - | $103.10 M(-11.4%) |
| Dec 2023 | $116.39 M | $116.39 M(-13.9%) |
| Sep 2023 | - | $135.19 M(-7.6%) |
| Jun 2023 | - | $146.26 M(+23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $118.28 M(-5.8%) |
| Dec 2022 | $125.58 M(+28.8%) | $125.58 M(+73.7%) |
| Sep 2022 | - | $72.28 M(-12.6%) |
| Jun 2022 | - | $82.71 M(-15.2%) |
| Dec 2021 | $97.49 M(+8715.0%) | - |
| Dec 2021 | - | $97.49 M |
| Dec 2020 | $1.11 M | - |
FAQ
- What is Acrivon Therapeutics annual working capital?
- What is the all time high annual working capital for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual working capital year-on-year change?
- What is Acrivon Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly working capital year-on-year change?
What is Acrivon Therapeutics annual working capital?
The current annual working capital of ACRV is $116.39 M
What is the all time high annual working capital for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual working capital is $125.58 M
What is Acrivon Therapeutics annual working capital year-on-year change?
Over the past year, ACRV annual working capital has changed by -$9.19 M (-7.32%)
What is Acrivon Therapeutics quarterly working capital?
The current quarterly working capital of ACRV is $174.16 M
What is the all time high quarterly working capital for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly working capital is $174.16 M
What is Acrivon Therapeutics quarterly working capital year-on-year change?
Over the past year, ACRV quarterly working capital has changed by +$38.97 M (+28.83%)